| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | US20050037995 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 02/17/2005 | DE10334174A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative |
| 02/17/2005 | DE10326918A1 Substituierte Alkylamide Substituted alkyl amides |
| 02/17/2005 | CA2534494A1 Pyrrole-based hmg-coa reductase inhibitors |
| 02/17/2005 | CA2531796A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506959A2 Derivatised molecules for mass spectrometry |
| 02/16/2005 | EP1506173A1 Method for producing cyclic imides in the presence of polyphosphoric acid |
| 02/16/2005 | EP1506172A2 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1506169A1 Method for the production of sulphamic acid halogenides |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 02/16/2005 | CN1580043A Anti malignant tumour southern radix bupleuri extract preparing method |
| 02/16/2005 | CN1580037A Symmetrical fluorene derivatives with multi proton absorption |
| 02/16/2005 | CN1189476C New thrombin inhibitors, their preparation and use |
| 02/16/2005 | CN1189457C Process for production of N-methyl pyrrolidone using gamma butyrolactone and mixed nethylamines as starting materials |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855745 Photopolyerization using photoinitiators |
| 02/15/2005 | US6855731 Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with nitro compounds |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855696 Antitumor agents |
| 02/15/2005 | US6855476 Produce a fluorinated alkyl sulfonic acid having a short perfluoroalkyl chain attached to an ether linkage. This ether linkage connects the fluorinated alkyl portion of the molecule with a variety of other substituents. |
| 02/10/2005 | WO2005012249A2 Adamantyglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 02/10/2005 | WO2005012247A1 Compounds and methods for the rapid quantitative analysis of proteins and polypeptides |
| 02/10/2005 | WO2005012246A1 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| 02/10/2005 | WO2005012245A1 Novel heteroaryl derivative |
| 02/10/2005 | WO2005012244A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | WO2005011675A1 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 02/10/2005 | WO2004108634A3 Reagents for modifying biopharmaceuticals, the use and production thereof |
| 02/10/2005 | US20050033150 Medicinal composition |
| 02/10/2005 | US20050033086 Chemical intermediates for statins |
| 02/10/2005 | US20050033064 Intermediates for the production of quinolone carboxylic acid derivatives |
| 02/10/2005 | US20050033063 Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with aryl and alkyl amines |
| 02/10/2005 | US20050033062 Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with aryl and alkyl amines |
| 02/10/2005 | US20050033061 Production of N-aryl-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050032752 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 02/10/2005 | US20050028953 In bleaching plant; catalytic oxidation of pulp slurry, washing, stabilization |
| 02/10/2005 | CA2534473A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/09/2005 | EP1505199A1 Methods for making carboxylated pulp fibers |
| 02/09/2005 | EP1503984A1 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1368315A4 Method for preparing amlodipine |
| 02/09/2005 | EP1235799B1 Polymorphic form of atorvastatin calcium |
| 02/09/2005 | EP1084269A4 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 02/09/2005 | EP0984931B1 Aromatic maleimides and their use as photoinitiators |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188420C Fungicides for preventing and curing full rot disease of plants |
| 02/09/2005 | CN1188419C Fungicides for control of full-rot disease of plants |
| 02/09/2005 | CN1188407C Imidazole derivatives with farnesyl transferase to inhibite activity and preparing method thereof |
| 02/09/2005 | CN1188392C Process for synthesis of hydrocarbonfluoride |
| 02/08/2005 | US6852864 Reaction pyrrole with formaldehyde in presense of cation exchange resin; chemical intermediate for porphyrin |
| 02/08/2005 | US6852814 Thermosetting resin compositions containing maleimide and/or vinyl compounds |
| 02/08/2005 | US6852752 Urea compounds, compositions and methods of use and preparation |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/05/2005 | CA2475665A1 Methods for making carboxylated pulp fibers |
| 02/03/2005 | WO2005009957A1 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2005009956A1 (2s,4s)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof |
| 02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2005009373A2 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2004087940A3 PROCESS FOR PRODUCING ENANTIOPURE β-AMINO ACID DERIVATIVES, AND ENANTIOPURE β-AMINO ACID DERIVATIVES |
| 02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
| 02/03/2005 | US20050027007 Allylamides useful in the treatment of alzheimer's disease |
| 02/03/2005 | US20050026993 Uses of ion channel modulating compounds |
| 02/03/2005 | US20050026991 mono-N-substituted amide monohydroxyamide derivatives, e.g., 1-Benzyl-3-(3,4-dichloro-benzyloxy)-1H-pyrrole-2,4-dicarboxylic acid 2-[(1-benzyl-piperidin-4-yl)-amide]4-hydroxyamide, that modulate levels of gene expression in cellular systems, including cancer cells |
| 02/03/2005 | US20050026990 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026936 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 02/03/2005 | US20050026913 N-substituted aniline and diphenylamine analogs; exhibit improved PDE4 inhibition; novel rolipram analogs which facilitate entry into cells, especially cells of the nervous system |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026874 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility |
| 02/03/2005 | US20050025702 radiotherapeutic or chemotherapeutic agents comprising metalloenzyme inhibitors and chelation compounds capable of conjugating to cytotoxic radioisotopes; anticarcinogenic agents |
| 02/03/2005 | DE19816479B4 Verfahren zur Herstellung von Enaminen, Iminen, Indolen und Diaminen aus Alkinen und deren Weiterverarbeitung durch katalytische Hydrierung Process for the preparation of enamines, imines, indoles and diamines from alkynes and their further processing by catalytic hydrogenation |
| 02/03/2005 | DE10335092B3 Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung Benzoylureido substituted-o-benzoylamide, processes for their preparation and their use |
| 02/03/2005 | CA2532443A1 Tyrosine kinase inhibitors |
| 02/03/2005 | CA2532400A1 Tyrosine kinase inhibitors |
| 02/03/2005 | CA2532397A1 (2s,4s)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1502576A2 Composition containing a 2-thioacetamide and use thereof for stimulating growth or preventing fall out of keratin fibres |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1501813A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |